Fairmount Funds Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.9M Hold
6,125,000
1.55% 16
2025
Q1
$13.4M Hold
6,125,000
2.08% 14
2024
Q4
$19.9M Buy
+6,125,000
New +$19.9M 1.98% 16